₹249.35 Crores | Listing at BSE, NSE | Mon, Jul 14, 2025 - Mon, Jul 28, 2025
Astec Lifesciences Limited Rights Issue comprises 0.2802 Cr equity shares aggregating to ₹249.35 Cr, offered at an issue price of ₹890 per share with a face value of ₹10 per share.
The record date for determining eligible shareholder is Jul 4, 2025, with the Rights Issue being offered in the entitlement ratio of 1 : 7.
The term of payment is defined as following : Issue Price of Rs 890/- per share is payable at the time of Application in the Rights Issue.
The Rights Entitlements are expected to be credited to eligible demat accounts on Jul 29, 2025.
The Rights Issue opens on Jul 14, 2025, and closes on Jul 28, 2025, with renunciation of Rights Entitlements permitted up to Jul 22, 2025.
The deemed date of allotment is Jul 29, 2025, following which the equity shares are expected to be credited to demat accounts on Jul 30, 2025 and listed at the NSE and the BSE on Aug 1, 2025.
MUFG Intime India Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Astec Lifesciences Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Fri, Jul 4, 2025
Entitlement Ratio
1 : 7
Open Date
Mon, Jul 14, 2025
Close Date
Mon, Jul 28, 2025
Issue Price of Rs 890/- per share is payable at the time of Application in the Rights Issue.
Astec Lifesciences Limited's revenue decreased by 17% and profit after tax (PAT) dropped by 187% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 |
| Revenue | 381.30 | 458.18 |
| Profit After Tax | -134.71 | -46.89 |
| Net Worth | 234.75 | 369.29 |
| Reserves and Surplus | 215.13 | 349.68 |
| Amount in ₹ Crore | ||
Incorporated in 1994, Astec Life Sciences limited manufactures agrochemical active ingredients, formulations, intermediates, and CDMO (Contract Development & Manufacturing) services, including herbicides and fungicides for international clients.
The company subsidiary of Godrej Agrovet (Godrej Industries Group), with Godrej holding ~62–65% stake as of early 2025.
The Company intends to utilise the Net Proceeds from the Issue towards funding of the following objects:
[Dilip Davda] ALL is engaged in agro chemicals manufacturing and marketing. For the last two fiscals, it posted degrowth in top and bottom lines. Losses widen from Rs. 46.89 cr. of FY24 to Rs. 134.71 cr. for FY25. The RI is aggressively priced, making it a highly risky bet. The company is operating in a highly competitive and fragmented segment. Investors may skip this costly RI of loss-making company. Read detail review...
Astec Lifesciences Rights Issue 2025 got subscribed by 0.96 times by the end of the bidding period with total bid quantity received by BSE and NSE of 26,77,385 shares. Check Day by Day Subscription Details (Live Status)
| Date | BSE Bid Quantity | NSE Bid Quantity | Total Bid Quantity | Subscription Times |
|---|---|---|---|---|
Jul 28 2025 17:00:00 | 25,72,335 | 1,05,050 | 26,77,385 | 0.96x |
Astec Lifesciences Limited
Godrej One, 3rd Floor,
Pirojshanagar, Eastern Express Highway,
Vikhroli (East),
The Astec Lifesciences Rights Issue 2025 opens on Mon, Jul 14, 2025, and closes on Mon, Jul 28, 2025.
Astec Lifesciences Rights Issue 2025 Schedule
| Last Date for credit of Rights Entitlements | Mon, Jul 7, 2025 |
| Last Date for renunciation of Rights Entitlements | Tue, Jul 22, 2025 |
| Issue Opening Date | Mon, Jul 14, 2025 |
| Issue Closing Date | Mon, Jul 28, 2025 |
| Date of Allotment (on or about) | Tue, Jul 29, 2025 |
| Date of Credit (on or about) | Wed, Jul 30, 2025 |
| Date of Listing (on or about) | Fri, Aug 1, 2025 |
You can apply for Astec Lifesciences Rights Issue 2025 in two ways:
Steps to apply for Astec Lifesciences Rights Issue 2025 using Net Banking (ASBA)
Steps to apply for Astec Lifesciences Rights Issue 2025 using Registrar's website (R-WAP)
